A Phase 2, single arm study of Safety and Efficacy of Coversin in adult aHUS subjects

Trial Profile

A Phase 2, single arm study of Safety and Efficacy of Coversin in adult aHUS subjects

Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Jun 2018

At a glance

  • Drugs Nomacopan (Primary)
  • Indications Atypical Haemolytic Uraemic Syndrome
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Akari Therapeutics
  • Most Recent Events

    • 21 Mar 2018 According to an Akari Therapeutics media release, this trial was initiated in fourth quarter of 2017.
    • 06 Feb 2018 Status changed from planning to recruiting, according to an Akari Therapeutics media release.
    • 27 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top